IRIS UniCatt

Innocenti, Idanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.503
AS - Asia 4.129
EU - Europa 3.183
SA - Sud America 934
Continente sconosciuto - Info sul continente non disponibili 240
AF - Africa 104
OC - Oceania 2
Totale 15.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.334
SG - Singapore 1.780
CN - Cina 1.018
BR - Brasile 742
IT - Italia 727
SE - Svezia 598
DE - Germania 518
VN - Vietnam 437
FR - Francia 363
IE - Irlanda 177
GB - Regno Unito 166
IN - India 165
FI - Finlandia 153
UA - Ucraina 133
BD - Bangladesh 130
ID - Indonesia 130
JP - Giappone 112
RU - Federazione Russa 86
CA - Canada 78
HK - Hong Kong 78
PL - Polonia 72
AR - Argentina 64
TR - Turchia 46
MX - Messico 43
EC - Ecuador 37
KR - Corea 36
IQ - Iraq 34
NL - Olanda 33
CO - Colombia 28
AT - Austria 27
CI - Costa d'Avorio 27
ES - Italia 24
BE - Belgio 21
PK - Pakistan 20
VE - Venezuela 18
ZA - Sudafrica 18
PY - Paraguay 16
UZ - Uzbekistan 15
MA - Marocco 14
SA - Arabia Saudita 14
CL - Cile 12
CZ - Repubblica Ceca 12
IL - Israele 12
CH - Svizzera 10
IR - Iran 10
CR - Costa Rica 9
EG - Egitto 9
JO - Giordania 9
KE - Kenya 9
PH - Filippine 9
DZ - Algeria 8
MY - Malesia 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
BO - Bolivia 7
GR - Grecia 7
HN - Honduras 7
JM - Giamaica 7
KZ - Kazakistan 7
BB - Barbados 6
OM - Oman 6
TN - Tunisia 6
LT - Lituania 5
PE - Perù 5
PT - Portogallo 5
SN - Senegal 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
KW - Kuwait 4
LK - Sri Lanka 4
MD - Moldavia 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
KH - Cambogia 3
NI - Nicaragua 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
MN - Mongolia 2
PA - Panama 2
QA - Qatar 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
Totale 14.837
Salva come PNG Salva come JPEG
Città #
Singapore 884
Chandler 625
Ashburn 601
San Jose 511
Beijing 235
Council Bluffs 179
Rome 176
Dublin 172
Los Angeles 136
Ho Chi Minh City 135
Lauterbourg 130
New York 122
Jacksonville 114
Jakarta 112
Hanoi 111
Hefei 105
Dearborn 102
San Mateo 98
Tokyo 98
Wilmington 90
Ann Arbor 84
Dallas 83
Chicago 80
Cattolica 74
Milan 74
Munich 74
Frankfurt am Main 71
Hong Kong 70
Nanjing 69
Hyderabad 68
Boston 67
Warsaw 66
Florence 61
Marseille 58
Princeton 57
Helsinki 56
Fairfield 54
Houston 54
São Paulo 51
Santa Clara 49
Woodbridge 49
Buffalo 48
Moscow 47
Atlanta 46
Lancaster 45
Seattle 44
Boardman 39
Nanchang 39
Tukwila 39
Orem 38
Brooklyn 36
Lappeenranta 34
Seoul 34
Bremen 33
Phoenix 31
Turku 30
Lawrence 29
Rio de Janeiro 29
Abidjan 27
Kent 26
Kunming 26
Shanghai 26
Denver 25
The Dalles 25
Naples 24
Redwood City 23
London 22
Paris 22
Shenyang 22
Brussels 21
Cambridge 21
Minneapolis 21
Stockholm 21
Tianjin 19
Toronto 19
Da Nang 18
Mexico City 18
Nuremberg 18
San Francisco 18
St Louis 18
Albany 17
Izmir 17
Montreal 17
Redmond 17
Washington 17
Detroit 16
Düsseldorf 16
Tampa 16
Vienna 16
Biên Hòa 15
Guangzhou 15
Tashkent 15
Zhengzhou 15
Elk Grove Village 14
Johannesburg 14
Las Vegas 14
Norwalk 14
Nürnberg 14
Pune 14
Haiphong 13
Totale 7.532
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 339
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 271
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 255
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 236
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR 231
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation 230
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 216
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 216
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 193
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 190
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 183
Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. 179
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 177
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy 176
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 175
The effects of omega-3 polyunsaturated fatty acids against cancer 172
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 169
Role of microRNAs in Chronic Lymphocytic Leukemia 162
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 160
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 160
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 156
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 155
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 150
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 149
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 148
Mycosis fungoides as a cause of severe obstructive sleep apnea 148
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 147
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 143
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 141
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 138
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 137
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 137
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 132
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 132
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 129
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 128
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 126
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 126
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 126
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 126
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 124
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 124
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 124
Unrelated cord blood transplantation and post-transplant cyclophosphamide 121
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 118
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 117
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 116
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 115
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 115
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 114
Second haploidentical stem cell transplantation for primary graft failure 114
Richter transformation in Chronic Lymphocytic Leukemia 112
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 111
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 109
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 109
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 109
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 109
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 108
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 106
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 106
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 106
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 105
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 104
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 104
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 104
Unrelated cord blood transplantation and post-transplant cyclophosphamide 103
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 102
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 102
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 101
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 101
Validation of the CLL-IPI and comparison with the MDACC prognostic index: analysis of 1364 newly diagnosed patients 101
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 100
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 99
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 98
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 98
The concomitance of lymphoma and breast carcinoma in the bone 98
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation 96
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 94
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 94
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 94
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 94
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 93
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 93
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 91
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 91
Second haploidentical stem cell transplantation for primary graft failure 90
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 89
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 89
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab 89
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 88
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 88
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 87
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 85
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 85
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 84
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 83
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 82
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 82
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 82
Totale 12.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022604 0 0 0 36 51 12 8 109 24 39 175 150
2022/20231.756 239 232 124 245 138 226 102 134 193 42 64 17
2023/2024965 44 259 61 60 40 133 67 34 15 43 100 109
2024/20252.122 46 67 139 73 165 64 58 86 258 248 562 356
2025/20265.625 772 188 367 653 860 310 907 320 396 410 225 217
2026/20271.890 302 1.021 400 167 0 0 0 0 0 0 0 0
Totale 15.095